Company:  ATYR PHARMA INC (LIFE)
Form Type:  8-K
Filing Date:  4/21/2020 
CIK:  0001339970 
Address:  3545 JOHN HOPKINS COURT, STE #250 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  858-731-8389 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.31  
Change: 
0.09 (2.13%)  
Trade Time: 
Sep 18  
Market Cap: 
$42.85M
Trade LIFE now with

© 2020  
Description of Business
We are a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. We have concentrated our research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Built on more than a decade of foundational science on extracellular tRNA synthetase biology and its effect on immune responses, we have built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets, such as neuropilin-2 (NRP2). Our primary focus is on ATYR1923, a clinical stage product candidate which binds to the NRP2 receptor and is designed to down regulate immune engagement in interstitial lung diseases (ILDs).
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01. Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01Financial Statements and Exhibits.
    SIGNATURE
  EXHIBIT 99.1